| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 02/15/2011 | US7888056 Method of forming a peptide-receptor complex with zsig33 |
| 02/15/2011 | US7888052 detecting a Cripto polypeptide; for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; bind Cripto and block the interaction between Cripto and activin-like kinase (ALK) 4 |
| 02/15/2011 | US7887810 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 02/15/2011 | US7887799 Antibodies to fibroblast growth factor-like polypeptides |
| 02/15/2011 | CA2519993C Ph-dependent polypeptide aggregation and its use |
| 02/15/2011 | CA2452445C Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 02/15/2011 | CA2433535C Materials and methods relating to protein aggregation in neurodegenerative disease |
| 02/15/2011 | CA2433071C Use of transcription factor yb-1 in adenoviral systems |
| 02/15/2011 | CA2429473C Membrane scaffold proteins |
| 02/15/2011 | CA2294223C Anti-cd40l immunotoxins for the treatment of diseases |
| 02/10/2011 | US20110033483 Single-chain multivalent binding proteins with effector function |
| 02/10/2011 | US20110033389 Modified antibodies for passive immunotherapy |
| 02/10/2011 | US20110033378 Cysteine Engineered Antibodies For Site-Specific Conjugation |
| 02/10/2011 | CA2769262A1 Methods and compositions for treating trinucleotide repeat disorders |
| 02/10/2011 | CA2768990A1 Broad spectrum erbb ligand binding molecules and methods for preparing and using them |
| 02/09/2011 | EP2281891A2 Streptococcus antigens |
| 02/09/2011 | EP2281843A1 Antibodies that immunospecifically bind to blys |
| 02/09/2011 | EP2281842A1 Antibodies that immunospecifically bind to BLyS |
| 02/09/2011 | EP2281007A2 Anti-atheroma vaccine |
| 02/09/2011 | EP2085475B1 Method for production of cell strain capable of tetracycline-induced gene expression or cell strain having conditional gene knockout, and use of the cell strains |
| 02/09/2011 | EP0848755B2 Vegf-related protein |
| 02/09/2011 | EP0668777B2 Prostate-specific membrane antigen |
| 02/09/2011 | CN101970678A Biological active proteins having increased in vivo and/or vitro stability |
| 02/09/2011 | CN101970647A Engineering zymogen for conditional toxicity |
| 02/09/2011 | CN101970498A Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof |
| 02/09/2011 | CN101970478A Modulation of sirpalphalpha - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 02/09/2011 | CN101970469A Production of heterologous proteins or peptides |
| 02/09/2011 | CN101970456A Tag peptide and use thereof |
| 02/09/2011 | CN101969975A Chimeric HIV fusion proteins as vaccines |
| 02/09/2011 | CN101967196A Interferon fusion protein, preparation thereof and application thereof |
| 02/09/2011 | CN101967195A Thrombolysis-targeting fusion protein mAnxB1ScuPA, structure and application thereof |
| 02/09/2011 | CN101967194A Recombinant human cell restin MHD fusion protein and preparation method thereof |
| 02/09/2011 | CN101967193A Hsp60 fragment capable of being combined with LOX-1, derivatives thereof and use thereof |
| 02/09/2011 | CN101967192A Fusion protein of anti-CD20 antibody fragment and lidamycin (LDM) as well as preparation method and application thereof |
| 02/09/2011 | CN101280021B Engineered protein VP28-C against shrimp white spot syndrome virus, preparation and use thereof |
| 02/09/2011 | CN101121752B Short peptide fusion expression heat induced recombinant plasmid using streptavidin as carrier and preparation method thereof |
| 02/08/2011 | US7883896 for early diagnosis, prognosis and monitoring of the disease course and for therapy and vaccination of cell proliferative disorders such as lung adenocarcinoma, lung carcinoma |
| 02/08/2011 | US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders |
| 02/08/2011 | US7883845 using Human immunodeficiency virus-1 group O/M envelope polypeptide fusion as evaluative tool in diagnosing viral infection |
| 02/08/2011 | US7883706 Methods for using Streptococcus pyogenes polypeptides |
| 02/08/2011 | CA2325566C Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 02/08/2011 | CA2314186C Adjuvanted vaccine comprising a cpg oligonucleotide and an antigen from streptococcus pneumoniae |
| 02/08/2011 | CA2210467C Osteoprotegerin |
| 02/08/2011 | CA2184059C Human trk receptors and neurotrophic factor inhibitors |
| 02/03/2011 | WO2011013470A1 Autoantibody production inhibitor |
| 02/03/2011 | WO2011011976A1 Homing peptide for tumor vasculature |
| 02/03/2011 | WO2011011973A1 Fusion protein of anti-cd20 antibody fab fragment and lidamycin, preparation method and use thereof |
| 02/03/2011 | WO2011011906A1 A fusion heparinase, its coding gene and use |
| 02/03/2011 | WO2010091294A9 New targeted antimicrobial moieties |
| 02/03/2011 | US20110028696 Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues |
| 02/03/2011 | US20110028691 Recombinant toxin fragments |
| 02/03/2011 | US20110028402 Substance p-saporin (sp-sap) conjugates and methods of use |
| 02/03/2011 | US20110027805 Acpl-related assays |
| 02/02/2011 | EP2280071A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 02/02/2011 | EP2280066A2 Recombinant Clostridium neurotoxin fragments |
| 02/02/2011 | EP2279755A2 Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF) |
| 02/02/2011 | EP2279754A2 Remodelling and glycoconjugation of human growth hormone (hGH) |
| 02/02/2011 | EP2279753A2 Remodeling and glycoconjugation of peptides |
| 02/02/2011 | EP2279210A2 Lysosomal targeting peptides and uses thereof |
| 02/02/2011 | EP2279203A2 Prion epitopes and methods of use thereof |
| 02/02/2011 | EP1364212B1 Three hybrid assay system |
| 02/02/2011 | CN101962413A Fusion protein with transdermal capability and interleukin-10 activity as well as coding gene and application thereof |
| 02/02/2011 | CN101962412A Recombinant TAT-XIAP fusion protein |
| 02/02/2011 | CN101962411A Dengue virus serology early diagnosis reagent |
| 02/02/2011 | CN101362803B Fusion proteins of tick anticoagulant peptide and staphylococcus aureus superantigen-like protein, preparation and application thereof |
| 02/01/2011 | US7879990 Polynucleotides encoding antibodies that bind to the C35 polypeptide |
| 02/01/2011 | US7879988 Fluorescent proteins from Aequorea coerulscens and methods for using the same |
| 02/01/2011 | US7879334 Bifunctional fusion protein capable of binding to a immunoglobulin inhibitory receptor comprising an immune receptor tyrosine-based inhibitory motif (ITIM), expressed on mast cells, basophils or B cells for use in treatment of allergic disorders |
| 02/01/2011 | US7879324 Using Fc epsilon R specific immunoglobulin fusion to treat and/or prevent type I hypersensitivity reaction |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
| 02/01/2011 | US7879319 Selectively delivering interleukin-12 (IL-12) to a target antigen in a mammal |
| 01/27/2011 | WO2011011347A2 Functionalization of silk material by avidin-biotin interaction |
| 01/27/2011 | WO2011009218A1 Raf dimers and uses thereof |
| 01/27/2011 | WO2010141312A3 Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same |
| 01/27/2011 | US20110021441 Conjugate comprising p21 protein for the treatment of cancer |
| 01/27/2011 | US20110020357 Anti human immunodeficiency antibodies and uses thereof |
| 01/27/2011 | US20110020343 Auristatin drug linker conjugates |
| 01/27/2011 | US20110020342 Igf-1 fusion polypeptides and therapeutic uses thereof |
| 01/27/2011 | US20110020340 Antibody-light fusion products for cancer therapeutics |
| 01/27/2011 | US20110020219 Anti-human tenascin monoclonal antibody |
| 01/27/2011 | CA2768042A1 Raf dimers and uses thereof |
| 01/26/2011 | EP2278013A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2277910A1 Albumin fusion proteins |
| 01/26/2011 | EP2277897A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2277893A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/26/2011 | EP2277892A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/26/2011 | EP2277890A1 Peptide capable of extending half-life of peptide of interest in plasma |
| 01/26/2011 | EP2277889A2 Fusion proteins of albumin and interferon beta |
| 01/26/2011 | EP2277888A2 Fusion proteins of albumin and erythropoietin |
| 01/26/2011 | EP1581649B1 Binding agents which inhibit myostatin |
| 01/26/2011 | CN101955545A Multi-target recombination gene and application of protein thereof in preventing and treating infection of helicobacter pylori |
| 01/26/2011 | CN101955544A Candida albicans secreted aspartic proteinase (Sap2) coding epitope sequence-synthesizing and bacteriophage shell protein-bonding hybrid protein and use thereof |
| 01/26/2011 | CN101955543A Nerve growth factor bound with laminin, and coding gene and application thereof |
| 01/26/2011 | CN101955524A CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses |
| 01/26/2011 | CN101954066A Medicament for promoting repair of peripheral nerve injury |
| 01/26/2011 | CN101538578B Recombinant bovine tuberculosis specific antigen protein with three fused genes and preparation method thereof |
| 01/26/2011 | CN101481691B Trichinella spiralis 70KDa heat shock protein and use thereof |
| 01/26/2011 | CN101280022B Fused protein of D-aminoacid oxidase, carrier and application thereof |
| 01/26/2011 | CN101139399B Fused protein restructuring target lethal leukemia cells and preparation method and use thereof |
| 01/25/2011 | US7875450 Virus-like particles for the induction of autoantibodies |